QUOTE AND NEWS
newratings.com  Jul 30  Comment 
Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, ...
newratings.com  Jul 30  Comment 
BRUSSELS (dpa-AFX) - The European Commission Wednesday said it has approved the acquisition of Perrigo of Ireland by Mylan of the Netherlands, under the EU Merger Regulation. Mylan is one of the major European prescribed generic drug maker....
FiercePharma  Jul 29  Comment 
Teva's $40.5 billion deal to buy Allergan's generics business ended its pursuit of Mylan and left its rival the chance to snap up its own hostile target, Perrigo. But the way some analysts see it, things won't necessarily go that way.
newratings.com  Jul 29  Comment 
CANONSBURG (dpa-AFX) - Mylan N.V. (MYL) announced that it received regulatory clearance from the European Commission under the European Union Merger Regulation or EUMR for its proposed acquisition of Perrigo Company plc (PRGO). Mylan recently...
newratings.com  Jul 29  Comment 
Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, ...
newratings.com  Jul 28  Comment 
Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, ...
newratings.com  Jul 27  Comment 
CANONSBURG (dpa-AFX) - Mylan N.V. (MYL) on Monday said it will hold its extraordinary general meeting of shareholders in connection with its proposed acquisition of Perrigo Co plc (TASE) at the Okura Hotel Amsterdam on Friday, August 28,...
Market Intelligence Center  Jul 24  Comment 
Perrigo (PRGO) closed Thursday at $189.71 and technical indicators recently have been bullish. Based in part on those numbers, MarketIntelligenceCenter.com's patented algorithms have identified a couple of attractive trading opportunities in...
newratings.com  Jul 24  Comment 
Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, ...




 

Perrigo Company is a global health-care supplier and the world's largest manufacturer of over-the-counter pharmaceuticals for the store brand market. The company develops, distributes, and manufactures over-the-counter and prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients, and consumer products.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki